Mark Phillips is currently the Chief Clinical Officer at Harrison.ai, a position held since 2025. Previously, Mark has held significant roles in clinical affairs and research, including as Head of Global Clinical Affairs & Post-Market Surveillance at Cochlear from 2011 to 2016, and as Chief Clinical Officer at Annalise.ai from 2024 to 2025. Mark's expertise spans medical affairs, regulatory affairs, and reimbursement, and they have also served as a General Manager at AllVascular Pty Ltd and medical director roles at Teva Pharmaceuticals. Mark earned a PhD in Vascular Surgery from the University of Otago, which they completed in 1998.
This person is not in the org chart
This person is not in any teams
This person is not in any offices